Cell transplantation is a promising therapeutic strategy for SCI.
Respiratory dysfunction plays a critical role in patient outcome following SCI.
Transplant-based targeting of respiratory compromise has not been extensively explored.
A small number of studies to date have shown the potential power of such an approach.